Pig-to-human tissue transplants 'imminent'
Trials could begin in the US within two years – but British expert warns that safety fears remain
Jeremy Laurance is a writer on health issues. He is former health editor of The Independent and the i and has covered the specialism for more than 20 years. He thinks the harm medicine does is under-appreciated, the harm it prevents over-rated, and that cycling works better than most drugs. He was named Specialist Journalist of the Year in the 2011 British Press Awards.
Friday 21 October 2011
The world is on the cusp of a medical revolution which will see transplants of tissue from genetically engineered pigs to treat a range of human diseases, US scientists say today.
Click HERE to view graphic (103k jpg)
Human trials could begin within two to three years of tissue taken from specially bred pigs to help the millions of sufferers from diabetes, brain diseases and blindness.
But a British expert challenged their findings saying the safety issues were still "unresolved". The fear is that a retrovirus could jump from pigs to humans and trigger a new pandemic – HIV is thought to have started from a cross-species infection.
In a review of xenotransplantation – using animal tissue and organs to replace human ones – experts from the Thomas Starzl Transplantation Institute at the University of Pittsburgh say the technology has made "great strides".
During the mid-1990s, Imutran, a small biotechnology company in Cambridge, became the first in the world to transplant pigs' hearts into monkeys, demonstrating that cross-species transplantation was possible. However, immune system rejection problems proved more difficult than expected and safety fears dampened enthusiasm.
A decade on, attention has focused on the transplant of cells and tissues rather than organs – pancreatic islets for diabetics, brain cells for Parkinson's disease and corneas for the blind.
Problems remain, including loss of transplanted cells, blood clots and other rejection problems. New, genetically modified pigs will shortly become available which could overcome these issues and make human trials of transplanted tissue "imminent".
The US scientists discount safety fears saying retroviruses "do not pose a substantial risk".
That was challenged by Robin Weiss, professor of virology at University College, London, and an expert on retroviruses. He said yesterday: "I don't think the risk issues have been resolved. That doesn't mean clinical trials shouldn't go ahead but there would need to be very close monitoring of patients to ensure they were not picking something up from pigs."
Life & Style blogs
- 1 Mario Balotelli: Staff at arson-hit Manchester Dogs' Home convinced Liverpool striker is behind five-figure donation
- 2 Friends 20th anniversary: Alison Jackson photographs reunited cast
- 3 There is literally not a single woman in this iPhone 6 queue
- 4 Hitler’s former food taster reveals the horrors of the Wolf’s Lair
- 5 Scottish independence: Tory revolt against 'devo max' grows as Rail Minister Claire Perry joins
£30000 - £35000 per annum: Ashdown Group: Marketing Manager (CIM, B2B, MS Offi...
£22000 - £25000 per annum: Ashdown Group: A highly successful organisation wit...
£1 per day: Randstad Education Leeds: Job Purpose To work closely with the he...
£32000 - £42000 Per Annum: Clearwater People Solutions Ltd: Our client is curr...